One research of type 2 diabetes has shown that the maturation of caspase-1 and IL-1β, the sign of NLRP3 inflammation activation, did not required TXNIP in bone marrow-derived macrophages [48]. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.